{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:58:38Z","timestamp":1784689118356,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.yebeh.2017.04.042","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T13:48:38Z","timestamp":1496238518000},"page":"39-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The influence of levetiracetam on psychosocial and behavioral functioning in children: A case\u2013control and follow-up study"],"prefix":"10.1016","volume":"72","author":[{"given":"Gonca","family":"Bekta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U\u011fur","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis Ulak","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edibe Pembeg\u00fcl","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Ayd\u0131nl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2017.04.042_bb0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0010","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2004.10.004","article-title":"Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial","volume":"14","author":"Lagae","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/070674370404901222","article-title":"Drug-induced psychosis after long-term treatment with levetiracetam","volume":"49","author":"Bayerlein","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2007.04.008","article-title":"Suicidal ideation in epilepsy and levetiracetam therapy","volume":"11","author":"Mula","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10673229.2011.549777","article-title":"Levetiracetam, seizures, and suicidality","volume":"19","author":"Givon","year":"2011","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/j.1950-6945.2003.tb00573.x","article-title":"Acute psychosis associated with levetiracetam","volume":"5","author":"Youroukos","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.seizure.2014.06.004","article-title":"Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review","volume":"23","author":"Halma","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1090-3798(03)00041-2","article-title":"Effect of levetiracetam in refractory childhood epilepsy syndromes","volume":"7","author":"Lagae","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0065","doi-asserted-by":"crossref","first-page":"1218-2","DOI":"10.1212\/01.WNL.0000091865.46063.67","article-title":"Discontinuation of levetiracetam because of behavioral side effects: a case\u2013control study","volume":"61","author":"White","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1517\/14740338.6.3.241","article-title":"The safety of levetiracetam","volume":"6","author":"Sirsi","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yebeh.2007.08.003","article-title":"Psychopathology in children and adolescents with epilepsy: an investigation of predictive variables","volume":"12","author":"Turky","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yebeh.2007.05.002","article-title":"The effect of seizure severity on quality of life in epilepsy","volume":"11","author":"Harden","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/088307380201700109","article-title":"Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children","volume":"17","author":"Oguz","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2009.0238","article-title":"Antiepileptic drugs and psychopathology of epilepsy: an update","volume":"11","author":"Mula","year":"2009","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0095","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004583-200111000-00015","article-title":"Psychometric properties of the strengths and difficulties questionnaire","volume":"40","author":"Goodman","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S0007125000292131","article-title":"Reliability and validity of two self-rating scales in the assessment of childhood depression","volume":"11","author":"Fundudis","year":"1991","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.yebeh.2017.04.042_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2012.03603.x","article-title":"Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam","volume":"54","author":"Helmstaedter","year":"2013","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501730207X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501730207X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:47:01Z","timestamp":1750283221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501730207X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":21,"alternative-id":["S152550501730207X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.04.042","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of levetiracetam on psychosocial and behavioral functioning in children: A case\u2013control and follow-up study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}